Io BiotechIOBTQ
13F holders, Q1 2024 (March 31)18holders
2famous investors
$1.73avg. 13F price*
At the end of Q1 2024, 18 institutions reported holding Io Biotech Inc. (IOBTQ) in their 13F filings. The largest holders were Vivo Capital, LLC ($10.7M), Novo Holdings A/S ($8.8M) and Samsara Biocapital, LLC ($6.3M). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Io Biotech Inc.
- CUSIP
- 449778109
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $657K |
| Exits | 3 | $40K |
Ownership 18 holders
| Vivo Capital, LLC | 0.84% | No change | 6,173,439 | $10.7M |
| Novo Holdings A/S | 0.61% | Reduce -11.5% | 5,088,258 | $8.8M |
| Samsara Biocapital, LLC | 0.97% | No change | 3,640,015 | $6.3M |
| PFM Health Sciences, LP | 0.21% | No change | 2,341,107 | $4.1M |
| Morgan Stanley | 0.00% | Reduce -3.7% | 2,197,234 | $3.8M |
| Marshall Wace, LLP | 0.01% | No change | 2,105,262 | $3.7M |
| Bank of America Corp. | 0.00% | No change | 1,844,185 | $3.2M |
| Armistice Capital, LLC | 0.08% | Reduce -10.4% | 1,724,000 | $3.0M |
| Pivotal bioVenture Partners Investment Advisor LLC | 0.96% | No change | 864,197 | $1.5M |
| Logos Global Management LP | 0.09% | No change | 493,827 | $854K |
| FMR LLC | 0.00% | New | 314,600 | $551K |
| Renaissance Technologies | 0.00% | Add +88.1% | 167,200 | $289K |
| Stonepine Capital Management, LLC | 0.21% | Reduce -90.6% | 156,167 | $270K |
| Bridgeway Capital Management, LLC | 0.00% | Reduce -14.2% | 124,623 | $218K |
| Citadel Advisors | 0.00% | Add +13.0% | 58,622 | $103K |
| Marex Group Ltd | 0.00% | New | 45,000 | $79K |
| Geode Capital Management, LLC | 0.00% | Add +161.6% | 33,307 | $58K |
| XTX Topco Ltd | 0.00% | New | 15,867 | $28K |
"% of holder's portfolio" is IOBTQ's weight in each manager's 13F, not the share of Io Biotech Inc. the manager owns.